BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 20497435)

  • 1. Infratemporal inflammatory myofibroblastic tumour with orbital extension.
    Chow SP; Nastri A; Hardy T
    Clin Exp Ophthalmol; 2010 Oct; 38(7):727-30. PubMed ID: 20497435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical strategy for tumors located in or extending from the intracranial space to the infratemporal fossa-Advantages of the transcranial approach (zygomatic infratemporal fossa approach) and the indications for a combined transcranial and transcervical approach-.
    Yoshida K; Kawase T; Tomita T; Ogawa K; Kawana H; Yago K; Asanami S
    Neurol Med Chir (Tokyo); 2009 Dec; 49(12):580-6. PubMed ID: 20035132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in pterygopalatine and infratemporal fossa malignant tumours: A single institution experience.
    He Y; Yang H; Sun J; Zhang C; Zhu H; Liu Z
    J Craniomaxillofac Surg; 2015 May; 43(4):537-44. PubMed ID: 25819099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliosarcoma with infratemporal fossa extension. Case report.
    Sade B; Prayson RA; Lee JH
    J Neurosurg; 2006 Dec; 105(6):904-7. PubMed ID: 17405263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Juvenile angiofibroma predominantly extending into the middle cranial fossa and eye-socket].
    Cherekaev VA; Belov AI; Kulikovskiĭ PV; Arustamian SR
    Zh Vopr Neirokhir Im N N Burdenko; 2006; (1):37-9; discussion 39-40. PubMed ID: 16739934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbitozygomatic approaches to skull base tumors spreading into the orbit, paranasal sinuses, nasal cavity, and pterygopalatine and infratemporal fossae.
    Cherekaev VA; Gol'bin DA; Belov AI; Radchenkov NS; Vinokurov AG; Bekyashev AK; Spallone A
    Zh Vopr Neirokhir Im N N Burdenko; 2015; 79(5):5-18. PubMed ID: 26528608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The orbito-zygomatic craniotomy in the treatment of giant tumor penetrating from maxillary-ethmoidal region to the anterior cranial fossa].
    Czecior E; Hendryk S; Namysłowski G; Mrówka R; Misiołek M
    Otolaryngol Pol; 2001; 55(3):273-8. PubMed ID: 11765442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography and magnetic resonance imaging findings of inflammatory myofibroblastic tumors of the head and neck.
    Gao F; Zhong R; Li GH; Zhang WD
    Acta Radiol; 2014 May; 55(4):434-40. PubMed ID: 23966365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant dumbbell-shaped middle cranial fossa trigeminal schwannoma with extension to the infratemporal and posterior fossae.
    Kouyialis AT; Stranjalis G; Papadogiorgakis N; Papavlassopoulos F; Ziaka DS; Petsinis V; Sakas DE
    Acta Neurochir (Wien); 2007; 149(9):959-63; discussion 964. PubMed ID: 17534571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maxillary-fronto-temporal approach for removal of recurrent malignant infratemporal fossa tumors: Anatomical and clinical study.
    Guo Y; Guo C
    J Craniomaxillofac Surg; 2014 Apr; 42(3):206-12. PubMed ID: 23932542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of recurrent adenoid cystic carcinoma in the deep infratemporal fossa by maxillo-orbito-zygomatic approach.
    Hongo T; Fukushima J; Uchida Y; Rikimaru F; Toh S; Higaki Y; Masuda M
    Auris Nasus Larynx; 2019 Dec; 46(6):921-926. PubMed ID: 30626547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fronto-orbito-zygomatic (FOZ) approach for infratemporal fossa lesions extending to middle cranial fossa: our experience and review of literature.
    Mancini F; Marini A; Paracino R; Consorti G; Iacoangeli M; Dobran M
    Neurol Neurochir Pol; 2022; 56(2):178-186. PubMed ID: 35302232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic endonasal approaches to infratemporal fossa tumors: a classification system and case series.
    Taylor RJ; Patel MR; Wheless SA; McKinney KA; Stadler ME; Sasaki-Adams D; Ewend MG; Germanwala AV; Zanation AM
    Laryngoscope; 2014 Nov; 124(11):2443-50. PubMed ID: 25513678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cranionasal surgery for spheno-orbital meningiomas invading the paranasal sinuses, pterygopalatine, and infratemporal fossa.
    Attia M; Patel KS; Kandasamy J; Stieg PE; Spinelli HM; Riina HA; Anand VK; Schwartz TH
    World Neurosurg; 2013 Dec; 80(6):e367-73. PubMed ID: 23072879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic Resection of Pterygopalatine Fossa and Infratemporal Fossa Malignancies.
    Oakley GM; Harvey RJ
    Otolaryngol Clin North Am; 2017 Apr; 50(2):301-313. PubMed ID: 28162242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transorbital approach to infratemporal fossa: novel technique.
    Mishra A
    J Laryngol Otol; 2011 Jun; 125(6):638-42. PubMed ID: 21329551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemifacial degloving approach to tumours in the infratemporal and pterygopalatine fossae: a preliminary report.
    Hirano A; Arakaki M; Nishida H; Hamada Y; Fujii T
    J Craniomaxillofac Surg; 1996 Oct; 24(5):285-8. PubMed ID: 8938510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic endonasal approach for the treatment of schwannomas of the pterygopalatine fossa: case report and review of the literature.
    Bresson D; McLaughlin N; Ditzel Filho LF; Griffiths CF; Carrau RL; Kelly DF; Kassam AB
    Neurochirurgie; 2014 Aug; 60(4):174-9. PubMed ID: 24952768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of eosinophilic granuloma of the infratemporal fossa: a successful treatment option.
    López F; Llorente JL; Suárez C
    Acta Otolaryngol; 2012 May; 132(5):558-62. PubMed ID: 22216878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infratemporal fossa fat enlargement in chronic maxillary atelectasis.
    Kohn JC; Rootman DB; Xu D; Goldberg RA
    Br J Ophthalmol; 2013 Aug; 97(8):1005-9. PubMed ID: 23766430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.